Temperature-controlled container specialist, Tower Cold Chain will be exhibiting its latest concept and products at the world’s largest pharmaceutical event, CPHI.
For the second consecutive year, Tower will be unveiling a new concept on its stand (3E72) which incorporates the company’s acclaimed robust, reliable and reusable passive container design with a brand-new innovation.
Alongside this, Tower will be showcasing its wide range of advanced, passive temperature-controlled solutions, which maintain thermally sensitive biotech and pharmaceutical shipments for 120 hours, without the need for manual intervention or a power source.
At its CPHI debut last year, the company saw plenty of interest in the launch of the KTEvolution – Tower’s lightest, manually handleable container, ideal for smaller shipments such as direct-to-patient, clinical trials and last-mile deliveries.
It can be expected that, akin to last year’s show, Tower Cold Chain’s latest products and updates will be similarly well received by attendees this year.
In addition, Tower has also appointed several new regional leads in the EMEA and US regions to further support customers and enhance access to localised expertise.
